Andesa Financial Management’s Gilead Sciences GILD Stock Holding History

Andesa Financial Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$256K	Buy	+1,303	New	+$108K	0.13%	110

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Andesa Financial Management's GILD Position: Q1 2023 in Review

Andesa Financial Management opened a new position in Gilead Sciences (GILD) in Q1 2023: 1,303 shares worth $256K. The stake represents 0.13% of the portfolio and ranks #110 among its holdings.

1,736 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

Andesa Financial Management held 1,303 shares of Gilead Sciences worth $256K as of Q1 2023.
Gilead Sciences was a new Andesa Financial Management position in Q1 2023.
Gilead Sciences made up 0.13% of Andesa Financial Management's portfolio in Q1 2023, its #110 holding.
1,736 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Andesa Financial Management's 13F filing for Q1 2023, filed 5 May 2023.